BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11356858)

  • 1. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
    Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
    Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
    Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
    J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
    Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
    Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(35)S]GTPĪ³S binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
    Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment.
    Narita M; Suzuki M; Mizoguchi H; Narita M; Yajima Y; Sakurada S; Tseng LF; Suzuki T
    Neurosci Lett; 2003 Feb; 338(2):103-6. PubMed ID: 12566163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord.
    Narita M; Mizoguchi H; Oji GS; Tseng EL; Suganuma C; Nagase H; Tseng LF
    Eur J Pharmacol; 1998 Jun; 351(3):383-7. PubMed ID: 9721032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
    Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.